Cargando…
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
BACKGROUND: The RANK ligand inhibitor denosumab is being investigated for treatment of giant cell tumor of bone, but the available data in the literature remains sparse and controversial. This study analyzes the results of combining denosumab with surgical treatment and highlights possible changes f...
Autores principales: | Müller, Daniel A., Beltrami, Giovanni, Scoccianti, Guido, Campanacci, Domenico A., Franchi, Alessandro, Capanna, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095954/ https://www.ncbi.nlm.nih.gov/pubmed/27809843 http://dx.doi.org/10.1186/s12957-016-1034-y |
Ejemplares similares
-
Latissimus dorsi rotational flap combined with a custom-made scapular prosthesis after oncological surgical resection: a report of two patients
por: Beltrami, Giovanni, et al.
Publicado: (2018) -
Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton
por: Campanacci, Domenico Andrea, et al.
Publicado: (2013) -
Custom-Made 3D-Printed Implants as Novel Approach to Reconstructive Surgery after Oncologic Resection in Pediatric Patients
por: Beltrami, Giovanni, et al.
Publicado: (2021) -
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results
por: Palmerini, Emanuela, et al.
Publicado: (2018) -
Allograft Reconstruction of the Extensor Mechanism after Resection of Soft Tissue Sarcoma
por: Müller, Daniel A., et al.
Publicado: (2018)